TARO - Taro Pharmaceutical Industries Ltd.

NYSE - NYSE Delayed Price. Currency in USD
115.45
+5.39 (+4.90%)
At close: 1:02PM EST
Stock chart is not supported by your current browser
Previous close110.06
Open110.86
Bid0.00 x 0
Ask125.00 x 100
Day's range109.40 - 115.54
52-week range94.00 - 128.46
Volume161,911
Avg. volume96,496
Market cap4.677B
Beta0.15
PE ratio (TTM)11.76
EPS (TTM)9.82
Earnings date7 Feb 2018 - 12 Feb 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est100.00
Trade prices are not sourced from all markets
  • Associated Press17 days ago

    Taro posts 2Q profit

    The Haifa Bay, Israel-based company said it had profit of $1.30 per share. The drug maker posted revenue of $169.9 million in the period. Taro shares have climbed almost 5 percent since the beginning of ...

  • Business Wire17 days ago

    Taro Provides Results for September 30, 2017

    November 7, 2017-- Taro Pharmaceutical Industries Ltd. today provided unaudited financial results for the three and six months ended September 30, 2017.

  • Business Wire25 days ago

    Taro to Announce Second Quarter Results on November 7, 2017

    Taro Pharmaceutical Industries Ltd. announced today that it plans to release its financial results for the quarter and six months ended September 30, 2017, on Tuesday, November 7, 2017.